Omi, Naomi
Yamamoto, Hayata
Yamaguchi, Taketo
Tsukiashi, Motoki
Yamamoto, Takayuki
Tanaka, Ryo
Watanabe, Koichi
Maruki-Uchida, Hiroko
Kawama, Toshihiro
Funding for this research was provided by:
Morinaga & Co. Ltd.
Article History
Received: 6 October 2022
Accepted: 10 April 2023
First Online: 8 May 2023
Declarations
:
: N.O. received research funding from Morinaga & Co., Ltd.; however, this does not comprise a conflict of interest. K.W. is a medical expert but has not been paid. M.T., T.Y., R.T., H.M.-U., and T.K. were employees of Morinaga & Co. Ltd.
: The University of Tsukuba Ethics Review Board approved the study protocol (2021.7.1, no. DAI-TAI.021-47). The study was conducted in accordance with the guidelines of the Declaration of Helsinki and approved by the Japan Conference of Clinical Research (January 17, 2020, no. 2020-001). trial was registered in the University Hospital Medical Information Network Clinical Trial Registry of Japan (registration no. UMIN000044791) in January 2020.
: Informed consent was obtained from all participants involved in the study.